SECSONAR

$KROS

Keros Therapeutics, Inc.

NASDAQ

85% below 52-week high

FCF positive · Revenue growing

New 8-K filing

Price

52-week range $9.55 – $70.48

52w low $9.55Now $10.82

Find before everyone else

SEC filings, insider trades & earnings for KROS — in one place.